Single-source·Aug 24, 2026·1 sources analyzed
Implant offers hope for patients with refractory angina
A new study indicates that a medical device significantly reduces chest pain for many patients. Further trials and approval from health authorities are necessary. (sources: theguardian)
Image: Modern Action subject: Medicare physician payment rules
Modern Action Briefing
The study reports that 75% of patients experienced a significant decrease in chest pain after receiving the implant. Patients expressed relief from the limitations of their condition.
- The device has shown a significant reduction in chest pain for 75% of participants in the study.
- Patients reported improved quality of life after receiving the implant.
- Further clinical trials and approval from the National Health Service are required before widespread use.
Why it matters
This development could provide new treatment options for individuals suffering from refractory angina.
Connected public decisions
Follow the issue pages where this story connects to public action.
Contact officials
Act on Coverage and payment for emerging medical technology
See the current decision, choose your position, and send a message through the issue page.
Take action on Coverage and payment for emerging medical technologySources used · 1 source